(Q45933567)

18 December 2017

title

Sterilizing activity of R207910 (TMC207)-containing regimens in the murine model of tuberculosis. (English)

1 reference

18 December 2017

1 reference

1 reference

1 reference

5

1 reference

18 December 2017

author name string

Murad Ibrahim

1

1 reference

18 December 2017

Chantal Truffot-Pernot

2

1 reference

18 December 2017

Koen Andries

3

1 reference

18 December 2017

Vincent Jarlier

4

1 reference

18 December 2017

language of work or name

English

0 references

publication date

9 July 2009

1 reference

18 December 2017

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

18 December 2017

volume

180

1 reference

18 December 2017

issue

6

1 reference

18 December 2017

page(s)

553-557

1 reference

18 December 2017

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1152OC

New small-molecule synthetic antimycobacterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1152OC

A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1152OC

OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1152OC

Moxifloxacin-containing Regimen Greatly Reduces Time to Culture Conversion in Murine Tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1152OC

Synergistic activity of R207910 combined with pyrazinamide against murine tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1152OC

Combinations of R207910 with drugs used to treat multidrug-resistant tuberculosis have the potential to shorten treatment duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1152OC

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1152OC

Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1152OC

The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1152OC

Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1152OC

Efficient intermittent rifapentine-moxifloxacin-containing short-course regimen for treatment of tuberculosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1152OC

Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1152OC

Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1152OC

Activities of pefloxacin and ofloxacin against mycobacteria: in vitro and mouse experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1152OC

Efficacy of intermittent pyrazinamide in experimental murine tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1152OC

Powerful bactericidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1152OC

A once-weekly R207910-containing regimen exceeds activity of the standard daily regimen in murine tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1152OC

Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1152OC

Early bactericidal activity and pharmacokinetics of the diarylquinoline TMC207 in treatment of pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1152OC

Evaluation of new antituberculosis drugs in mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200807-1152OC

10.1164/RCCM.200807-1152OC

21 January 2018

Identifiers

DOI

1 reference

18 December 2017

PubMed ID

19590024

1 reference

18 December 2017